marijuana stocks news

Form 8-K for INSYS THERAPEUTICS, INC.


6-Aug-2015

Results of Operations and Financial Condition, Financial Statements and

Item 2.02 Results of Operations and Financial Condition.On August 6, 2015, Insys Therapeutics, Inc. (the “Company”) issued a press release announcing its financial results for the first quarter ended June 30, 2015. A copy of this press release is attached hereto as Exhibit 99.1.

The information in this Item 2.02 and Exhibit 99.1 hereto are being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, nor shall they be deemed incorporated by reference into any filing under the Exchange Act or the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such a filing.

 

Item 9.01 Financial Statements and Exhibits.(d) Exhibits.

Exhibit
No. Description

99.1 Press Release dated August 6, 2015


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$INSY Announces Its Naloxone Sublingual Spray Received Fast Track Designation

Insys Therapeutics Announces Its Naloxone Sublingual Spray Received Fast Track Designation From…

INSYS Therapeutics, Inc. (INSY) Initiates Phase 3 Clinical Trial of Cannabidiol (CBD) Oral Solution

INSYS Therapeutics Initiates Phase 3 Clinical Trial of Cannabidiol (CBD) Oral Solution…

Cresco Labs (CRLBF) to Report Second Quarter 2023 Financial Results on August 16, 2023 Business Wire

Cresco Labs to Report Second Quarter 2023 Financial Results on August 16,…

Fire & Flower Holdings Corp. (FFLWF) and Alimentation Couche-Tard Enter Into a Master Licensing Agreement

Fire & Flower and Alimentation Couche-Tard Enter Into a Master Licensing Agreement…